OSTEOSYNTHETIC TRANS

Brand	Owner	Address	Description
OSTEOTRANS	TAKIRON CO., LTD.	3-1-3, Umeda, Kita-Ku, Osaka-Shi Osaka Japan	OSTEOSYNTHETIC TRANS;Bioresorbable fixation bone implants composed of artificial materials for osteosynthetic use;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention is directed to a process for producing trans-4-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into trans-4-hydroxy-L-proline in the presence of an enzyme source which is derived from a microorganism belonging to the genus Dactylosporangium, Amycolatopsis or Streptomyces and which catalyzes the hydroxylation of L-proline into trans-4-hydroxy-L-proline, a divalent iron ion and 2-ketoglutaric acid, in an aqueous medium, and the produced trans-4-hydroxy-L-proline is collected from the aqueous medium. In addition, the present invention is directed to a process for producing trans-4-hydroxy-L-proline, wherein the L-proline biosynthesis activity of the host cell of the transformant is reinforced.